SHANGHAI FOSUN PHARMACEUTICAL GROUP revenue breakdown overview

SHANGHAI FOSUN PHARMACEUTICAL GROUP revenue for the last year amounted to 43.54 B HKD, the most of which — 31.36 B HKD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 33.40 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI FOSUN PHARMACEUTICAL GROUP 32.28 B HKD, and the year before that — 34.29 B HKD.